30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Posts Tagged ‘NASDAQ:KRTX’
Bronte Amalthea Fund Incurred Loss in Karuna Therapeutics (KRTX) Short Position
Bronte Capital, an investment management company, released its “Amalthea Fund” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Karuna Therapeutics (KRTX) Rose on Acquisition Announcement
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2023 investor letter.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Karuna Therapeutics Third Quarter 2023 Financial Results Conference Call. All participants are in a listen-only mode.
What Makes Karuna Therapeutics (KRTX) a Prospective Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” second quarter 2023 investor letter.
5 Best High Risk High Reward Stocks To Buy Now
In this piece, we will take a look at the five best high risk high reward stocks to buy now.
10 Oversold Healthcare Stocks to Buy
In this article, we will take a look at the 10 healthcare stocks to buy.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Karuna Therapeutics Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note that this call is being recorded.
Karuna Therapeutics, Inc. (NASDAQ:KRTX) Q1 2023 Earnings Call Transcript
Operator: Welcome to the Karuna Therapeutics First Quarter 2023 Financial Results Conference Call. All participants are in a listen-only mode.
11 Best Mid-Cap Healthcare Stocks To Buy Now
In this article, we discuss 11 best mid-cap healthcare stocks to buy now.
12 Most Promising Healthcare Stocks According to Analysts
In this article, we will take a look at the 12 most promising healthcare stocks according to analysts.
Is Karuna Therapeutics (KRTX) Stock Bullish Now?
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” third quarter 2022 investor letter.
10 Best-Performing Non-Energy Stocks of 2022
On Friday, September 16, Wall Street concluded another one of its abysmal weeks in months, as investors reacted to a weak earnings indication from FedEx regarding the global economy...
Here’s What Makes Karuna Therapeutics (KRTX) a Great Investment Choice
Miller Value Partners, an investment management firm, published its “Miller Opportunity Trust Fund” second quarter 2022 investor letter – a copy of which can be downloaded...
5 Best Healthcare Stocks to Buy According to Matthew Halbower’s Pentwater Capital Management
In this article, we discuss the 5 best healthcare stocks to buy according to Matthew Halbower's Pentwater Capital Management.
Hedge Funds Are Crazy About Karuna Therapeutics, Inc. (KRTX)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is It Too Late to Buy Karuna Therapeutics (KRTX) Stock?
Miller Value Partners recently released its Q1 2021 Investor Letter, a copy of which you can download here.
Is KRTX A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think Karuna Therapeutics, Inc. (NASDAQ:KRTX) is a good investment right now.
Hedge Funds Keep Buying Karuna Therapeutics, Inc. (KRTX)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Hedge Funds Have Never Been This Bullish On Karuna Therapeutics, Inc. (KRTX)
We hate to say this but, we told you so.
Is Karuna Therapeutics, Inc. (KRTX) A Good Stock To Buy ?
Hedge funds are not perfect. They have their bad picks just like everyone else.
Hedge Fund and Insider Trading News: Anthony Scaramucci, Tangency Capital, Vermillion, Inc. (VRML), Xerox Corp (XRX), and More
Former White House communications director Anthony Scaramucci sees a landslide re-election for President Donald Trump in 2020, saying on Wednesday that voters will be wary of ...
